Gross Profit for IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's current gross profit (TTM) is $2.66B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$2.66B
YoY change
+11.8%
5Y CAGR
+11.1%
Peak year (2025)
$2.66B
Cumulative gross profit
$26.05B
Gross Profit history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Gross Profit history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $2.66B | +11.8% | ||
| 2024 | $2.38B | +8.6% | ||
| 2023 | $2.19B | +9.3% | ||
| 2022 | $2.00B | +6.1% | ||
| 2021 | $1.89B | +20.3% | ||
| 2020 | $1.57B | +15.0% | ||
| 2019 | $1.37B | +10.0% | ||
| 2018 | $1.24B | +13.1% | ||
| 2017 | $1.10B | +12.5% | ||
| 2016 | $975.44M | +9.6% | ||
| 2015 | $890.27M | +9.1% | ||
| 2014 | $816.12M | +7.9% | ||
| 2013 | $756.12M | +8.1% | ||
| 2012 | $699.15M | +8.1% | ||
| 2011 | $646.51M | +11.7% | ||
| 2010 | $578.62M | +9.9% | ||
| 2009 | $526.28M | -0.7% | ||
| 2008 | $529.77M | +14.3% | ||
| 2007 | $463.52M | +22.1% | ||
| 2006 | $379.53M | +17.5% | ||
| 2005 | $322.90M | +15.7% | ||
| 2004 | $279.02M | +21.2% | ||
| 2003 | $230.30M | +19.5% | ||
| 2002 | $192.72M | +5.1% | ||
| 2001 | $183.33M | -6.8% | ||
| 2000 | $196.66M | +2.8% | ||
| 1999 | $191.30M | +7.7% | ||
| 1998 | $177.70M | +24.1% | ||
| 1997 | $143.20M | -13.1% | ||
| 1996 | $164.80M | +45.3% | ||
| 1995 | $113.40M | +45.9% | ||
| 1994 | $77.70M | +31.9% | ||
| 1993 | $58.90M | +63.6% | ||
| 1992 | $36.00M | +92.5% | ||
| 1991 | $18.70M | — |
Gross Profit values are taken from IDEXX Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, IDEXX Laboratories (IDXX) reported gross profit of $2.66B – grew 11.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, IDEXX Laboratories gross profit compounded at +11.1% per year, sustaining 16 straight years of year-over-year growth.
The highest annual gross profit of $2.66B was reported in 2025. The lowest in the available history was $18.70M in 1991.
IDEXX Laboratories (IDXX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $53.80B.
IDEXX Laboratories Gross Profit by Year
IDEXX Laboratories Gross Profit 2025: $2.66B
IDEXX Laboratories gross profit in 2025 was $2.66B, grew 11.8% from 2024. This figure represents the highest annual value in the available history.
IDEXX Laboratories Gross Profit 2024: $2.38B
IDEXX Laboratories gross profit in 2024 was $2.38B, grew 8.6% from 2023.
IDEXX Laboratories Gross Profit 2023: $2.19B
IDEXX Laboratories gross profit in 2023 was $2.19B, grew 9.3% from 2022.
IDEXX Laboratories Gross Profit 2022: $2.00B
IDEXX Laboratories gross profit in 2022 was $2.00B, grew 6.1% from 2021.
IDEXX Laboratories Gross Profit 2021: $1.89B
IDEXX Laboratories gross profit in 2021 was $1.89B.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers — Gross Profit
Companies in the same sector as IDEXX Laboratories, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is IDEXX Laboratories's gross profit?
- Latest reported gross profit for IDEXX Laboratories (IDXX) is $2.66B (period ending December 31, 2025).
How has IDEXX Laboratories gross profit changed year-over-year?
- IDEXX Laboratories (IDXX) gross profit changed +11.8% year-over-year on the latest annual filing.
What is the long-term growth rate of IDEXX Laboratories gross profit?
- IDEXX Laboratories (IDXX) gross profit compound annual growth rate is +11.1% over the most recent 5 years available.
When did IDEXX Laboratories gross profit hit its highest annual value?
- IDEXX Laboratories gross profit reached its highest annual value of $2.66B in 2025.
What was IDEXX Laboratories gross profit in 2024?
- IDEXX Laboratories (IDXX) gross profit in 2024 was $2.38B.
What was IDEXX Laboratories gross profit in 2025?
- IDEXX Laboratories (IDXX) gross profit in 2025 was $2.66B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
IDXX Overview
Company profile, financial tools, and key metrics
IDXX Revenue Counter
Earns $136.47 every second. See per minute, hour, and day.
IDXX Earnings Counter
Earns $33.60 per second net profit. See per minute, hour, and day.
IDXX Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
IDXX What If Invested
What if you had invested $1,000? See historical returns from any date.
IDXX How It Makes Money
Discover visual breakdown of $4.30B in revenue — where it comes from and where it goes.
IDXX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IDXX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IDXX Daily Price Character
Explosive · 50.9% historical win rate (green days). Streaks & record days.
IDXX Buybacks
2.25% TTM buyback yield. Shareholder yield & SBC comparison.
IDXX Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.